Discussion about this post

User's avatar
Anu's avatar

Bringing together public datasets, biology, and machine learning is exactly the kind of interdisciplinary thinking that drives innovation in cancer research. You’re asking the right kind of 'big' question — one that doesn’t have an easy answer but is worth pursuing. As you continue to develop your model, perhaps your work could eventually consider and feed into diagnostic tools or clinical decision-making? The biggest gap today is in diagnostics. For example, could the patterns you uncover in transcriptional regulatory networks help stratify patients into different risk groups earlier in their treatment journey? Could your model be tested against existing diagnostic frameworks or incorporated into a decision-support tool that physicians might one day use?

Even if clinical application is a longer-term goal, thinking about the diagnostic potential of your research now might help guide how you frame your results, evaluate performance, or even visualize your findings. It’s exciting to see this level of depth and ambition at such an early stage — keep pushing forward!

Expand full comment

No posts